My major research interest is in radiation therapy for lymphomas, genitourinary cancers—including prostate cancer, bladder cancer and seminoma—and late effects of treatment, especially second cancers. Current research activities include study of image guided precision radiotherapy. I also have a long-standing interest in cancer classification with an emphasis on staging and prognostic factors. In addition, my current interests include the application of modern information and communication technologies in cancer control.
Mary K Gospodarowicz
Still a long way to go to achieve multidisciplinarity for the benefit of patients: commentary on the ESMO position paper (Annals of Oncology 25(1): 9-15, 2014).
Ann Oncol. 2014 Sep;25(9):1863-5
Int J Radiat Oncol Biol Phys. 2014 Jul 1;89(3):446-7
Int J Cancer. 2014 Jul 15;135(2):371-8
Active breathing control for patients receiving mediastinal radiation therapy for lymphoma: Impact on normal tissue dose.
Pract Radiat Oncol. 2014 May-Jun;4(3):174-80
Lancet Oncol. 2014 Apr;15(4):378-80
Leuk Lymphoma. 2014 Mar 31;
Clinical features, management, and prognosis of an international series of 161 patients with limited-stage diffuse large B-cell lymphoma of the bone (the IELSG-14 study).
Oncologist. 2014 Mar;19(3):291-8
Clinical features, management and prognosis of multifocal primary bone lymphoma: a retrospective study of the international extranodal lymphoma study group (the IELSG 14 study).
Br J Haematol. 2014 Mar;164(6):834-40
The clinical features, management and prognosis of primary and secondary indolent lymphoma of the bone: a retrospective study of the International Extranodal Lymphoma Study Group (IELSG #14 study).
Leuk Lymphoma. 2014 Aug;55(8):1796-9
Cancer Clinical Research Unit (CCRU), Princess Margaret Cancer Centre
Professor, Department of Radiation Oncology, University of Toronto
President, Union for International Cancer Control (UICC)